10.7 C
London
Friday, March 29, 2024
HomeFinTechPanTHer Therapeutics: Closes $5.4M in Series A Funding

PanTHer Therapeutics: Closes $5.4M in Series A Funding

Date:

PanTHer Therapeutics Closes $5.4M in Series A Funding

  • PanTher Therapeutics, a Cambridge MA-based company advancing treatments for solid tumors, raised $5.4M in Series A funding
  • The round was led by Catalyst Health Ventures (CHV), with participation from Angel Physicians Fund (APF) and other notable investors
  • The company intends to use the funds to expands its development efforts and to initiate first clinical trial of novel localized treatment of pancreatic cancer
  • PanTher is an oncology company advancing new treatments for solid tumors through direct, localized, and sustained delivery of proven and novel therapeutic agents
  • The company’s lead candidate is designed to control tumor progression in pancreatic cancer and is integrated into a commonly used, minimally invasive staging procedure
  • PanTher’s platform technology can be adapted to treat additional solid tumor indications

Related stories

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories

spot_img